Definitive Contract HHSN261201300075C

<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&amp;D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...

The National Cancer Institute (NCI) awarded a $1,964,216.00 Firm Fixed Price contract to Pact &amp; Health LLC, a small business, for the development of an &quot;I-PARTS Integrated Platform for Anti-Cancer Radiation Therapeutics Screening&quot; under TOPIC 366. The contract has a period of performance through June 15, 2022. This contract is a definitive contract and was set aside for small businesses. The I-PARTS platform aims to support the NCI's research efforts in developing new...

This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a &quot;CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM&quot; under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...

The U.S. National Cancer Institute (NCI) awarded a $199,969.00 firm fixed-price definitive contract to Infotech Soft, Inc., a woman-owned small business, for the development of an &quot;Other Functions Scalable Automated Brain Tumor Segmentation&quot; solution. The contract was awarded on September 28, 2012, with a completion date of June 27, 2013. Infotech Soft, Inc. has a proven track record of delivering specialized software solutions and research services to various federal healthcare...

This is a $399,975.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Chromologic LLC, a minority-owned small business. The contract is for the development of an &quot;Organ-on-VascularNet Model for In Vitro Evaluation of Radiation and Drug Therapies.&quot; This research supports NCI's mission to address critical needs in cancer treatment and prevention. The contract has a firm...

This is a $182,050 firm fixed price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanoivd, Inc., a small disadvantaged, woman-owned business. The contract is for TAS::75 0849::TAS and has a total small business set-aside designation. The period of performance runs from the award date of September 30, 2010 through the ultimate completion date of March 30, 2011. Nanoivd, Inc. is the prime contractor, and no subcontractors are mentioned. The contract...

The National Cancer Institute awarded a $224,997.00 firm fixed-price definitive contract to Paganini Biopharma, Inc. for research and development in biomedical basic research. The contract has a performance period ending on September 17, 2015 and was awarded on September 18, 2014. This contract was not set aside for any specific business type. The National Cancer Institute is a civilian agency within the U.S. Department of Health and Human Services that conducts and supports cancer research.

This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...

This is a $300,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Coordination Pharmaceuticals Inc., a small business. The contract is for the detection, diagnosis, treatment, prevention, and research of pediatric cancers and/or rare cancers. It was awarded under a Small Business Innovation Research (SBIR) Concept Award Program, which is a &quot;Phase 0&quot; pilot program intended to encourage small businesses to develop innovative and...